newsfilter
← Latest News
Business Wire·

Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that company management will present at the H.C. Wainwright 1st Annual Mental Healt